在科佩普丁刺激试验中,患有多尿多症候群的患者的阿佩林水平
Chiara Angela Bizzozero1,2, Sophie Monnerat1,2, Fiona A Chapman3,4
1Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
European journal of endocrinology
|October 19, 2024
概括
在初级多滴症 (PP) 中,阿佩林水平比在科佩刺激测试期间的阿尔金因血管压素缺乏症 (AVP-D) 降低得多. 科佩仍然是区分AVP-D和PP的优越诊断标志物.
科学领域:
- 内分泌学 在内分泌学.
- 诊断医学 诊断医学 诊断医学
- 激素研究 研究 激素研究
背景情况:
- 在适当的患者管理中,区分 arginine vasopressin 缺乏症 (AVP-D) 和原发性多症 (PP) 是至关重要的.
- 科佩激发试验是诊断的标准,但了解其他激素反应可以改进诊断的准确性.
研究的目的:
- 在科佩平丁刺激试验期间,调查阿佩林的变化,这是一种对抗阿尔金压缩素 (AVP) 的激素,在科佩平丁刺激试验中.
- 评估apelin在区分AVP-D和PP的诊断效用.
主要方法:
- 一个多中心诊断研究的后期分析,涉及AVP-D或PP的门诊患者.
- 使用高血压盐水和氨酸输液进行了可佩丁刺激测试.
- 在基线和峰值刺激期间测量阿佩林水平,以确定变化和诊断准确性.
主要成果:
- 在PP和AVP-D组之间,阿佩林水平在基线时没有差异.
- 在高血压盐水刺激后,阿佩林在PP显著下降,但在AVP-D没有 (P = .022).
- 科佩的诊断准确度很高 (AUC为97.1%),而阿佩林的诊断准确度较低 (AUC为49.3%). 在阿尔金因之后,科佩的准确性仍然很高 (AUC为97.1%),而阿佩林的准确性是中等的 (AUC为60.5%).
结论:
- 与AVP-D相比,阿佩林在佩刺激后的PP下降幅度更大.
- 尽管观察到的变化,可佩仍然是区分AVP-D和PP的最有效生物标志物.
- 进一步的研究可能会在复杂的诊断场景中探索阿佩林和科佩的联合效用.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
173
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
173
01:15Hypoglycemia and Glucagon
153
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
153
01:30Spare Receptors
3.5K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.5K